{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:02:15Z","timestamp":1793898135969,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T00:00:00Z","timestamp":1770681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s13346-026-02051-7","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T13:50:15Z","timestamp":1770731415000},"page":"3420-3438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A mechanical reprogramming: synergistic tumor microenvironment normalization improves nano-immunotherapy delivery in prostate cancer via multiphysics modeling"],"prefix":"10.1007","volume":"16","author":[{"given":"Fatemeh","family":"Mirala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madjid","family":"Soltani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,10]]},"reference":[{"issue":"3","key":"2051_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2051_CR2","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrclinonc.2018.29","volume":"15","author":"D Fukumura","year":"2018","unstructured":"Fukumura D, et al. Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clin Oncol. 2018;15(5):325\u201340.","journal-title":"Nat Rev Clin Oncol"},{"issue":"5706","key":"2051_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1126\/science.1104819","volume":"307","author":"RK Jain","year":"2005","unstructured":"Jain RK. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science. 2005;307(5706):58\u201362.","journal-title":"Science"},{"issue":"7","key":"2051_CR4","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1073\/pnas.1919764117","volume":"117","author":"F Mpekris","year":"2020","unstructured":"Mpekris F, et al. Combining microenvironment normalization strategies to improve cancer immunotherapy. Proc Natl Acad Sci U S A. 2020;117(7):3728\u201337.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2051_CR5","doi-asserted-by":"publisher","first-page":"e104717","DOI":"10.1371\/journal.pone.0104717","volume":"9","author":"C Voutouri","year":"2014","unstructured":"Voutouri C, et al. Role of constitutive behavior and tumor-host mechanical interactions in the state of stress and growth of solid tumors. PLoS ONE. 2014;9(8):e104717.","journal-title":"PLoS ONE"},{"issue":"1","key":"2051_CR6","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/ncomms3516","volume":"4","author":"VP Chauhan","year":"2013","unstructured":"Chauhan VP, et al. Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels. Nat Commun. 2013;4(1):2516.","journal-title":"Nat Commun"},{"issue":"8","key":"2051_CR7","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/nbt0897-778","volume":"15","author":"G Helmlinger","year":"1997","unstructured":"Helmlinger G, et al. Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol. 1997;15(8):778\u201383.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"2051_CR8","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1073\/pnas.1700340114","volume":"114","author":"F Mpekris","year":"2017","unstructured":"Mpekris F, et al. Role of vascular normalization in benefit from metronomic chemotherapy. Proc Natl Acad Sci U S A. 2017;114(8):1994\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2051_CR9","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1073\/pnas.1815515116","volume":"116","author":"IX Chen","year":"2019","unstructured":"Chen IX, et al. Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer. Proc Natl Acad Sci U S A. 2019;116(10):4558\u201366.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2051_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.ymeth.2020.02.010","volume":"185","author":"M Hadjicharalambous","year":"2021","unstructured":"Hadjicharalambous M, Wijeratne PA, Vavourakis V. From tumour perfusion to drug delivery and clinical translation of in silico cancer models. Methods. 2021;185:82\u201393.","journal-title":"Methods"},{"key":"2051_CR11","doi-asserted-by":"publisher","first-page":"101989","DOI":"10.1016\/j.jddst.2020.101989","volume":"60","author":"FM Kashkooli","year":"2020","unstructured":"Kashkooli FM, et al. Effect of vascular normalization on drug delivery to different stages of tumor progression: In-silico analysis. Journal of Drug Delivery Science and Technology. 2020;60:101989.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"2","key":"2051_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3390\/pharmaceutics14020363","volume":"14","author":"M Mohammadi","year":"2022","unstructured":"Mohammadi M, et al. Numerical investigation on the anti-angiogenic therapy-induced normalization in solid tumors. Pharmaceutics. 2022;14(2):363.","journal-title":"Pharmaceutics"},{"key":"2051_CR13","doi-asserted-by":"publisher","first-page":"655781","DOI":"10.3389\/fonc.2021.655781","volume":"11","author":"F Moradi Kashkooli","year":"2021","unstructured":"Moradi Kashkooli F, et al. Enhanced drug delivery to solid tumors via drug-loaded nanocarriers: an image-based computational framework. Front Oncol. 2021;11:655781.","journal-title":"Front Oncol"},{"issue":"3","key":"2051_CR14","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s10439-024-03650-6","volume":"53","author":"A Piranfar","year":"2025","unstructured":"Piranfar A, et al. A comparative analysis of alpha and beta therapy in prostate cancer using a 3D image-based spatiotemporal model. Ann Biomed Eng. 2025;53(3):562\u201377.","journal-title":"Ann Biomed Eng"},{"issue":"6","key":"2051_CR15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/nrc3064","volume":"11","author":"WR Wilson","year":"2011","unstructured":"Wilson WR, Hay MP. Targeting hypoxia in cancer therapy. Nat Rev Cancer. 2011;11(6):393\u2013410.","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"2051_CR16","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1073\/pnas.1818322116","volume":"116","author":"C Voutouri","year":"2019","unstructured":"Voutouri C, et al. Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies. Proc Natl Acad Sci U S A. 2019;116(7):2662\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2051_CR17","unstructured":"Zuley M, et al. The cancer genome atlas prostate adenocarcinoma collection (TCGA-PRAD)(Version 4)[Data set]. Cancer Imaging Arch. 2016."},{"key":"2051_CR18","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s10278-013-9622-7","volume":"26","author":"K Clark","year":"2013","unstructured":"Clark K, et al. The cancer imaging archive (TCIA): maintaining and operating a public information repository. J Digit Imaging. 2013;26:1045\u201357.","journal-title":"J Digit Imaging"},{"issue":"43","key":"2051_CR19","doi-asserted-by":"publisher","first-page":"17561","DOI":"10.1073\/pnas.1215397109","volume":"109","author":"Y Huang","year":"2012","unstructured":"Huang Y, et al. Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy. Proc Natl Acad Sci U S A. 2012;109(43):17561\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"2051_CR20","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1158\/0008-5472.CAN-12-4521","volume":"73","author":"T Stylianopoulos","year":"2013","unstructured":"Stylianopoulos T, et al. Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res. 2013;73(13):3833\u201341.","journal-title":"Cancer Res"},{"issue":"3","key":"2051_CR21","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1021\/acsbiomaterials.0c01542","volume":"7","author":"S Kim","year":"2021","unstructured":"Kim S, et al. Microfluidic tumor vasculature model to recapitulate an endothelial immune barrier expressing FasL. ACS Biomater Sci Eng. 2021;7(3):1230\u201341.","journal-title":"ACS Biomater Sci Eng"},{"issue":"2","key":"2051_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.pbiomolbio.2011.06.006","volume":"106","author":"Y Kim","year":"2011","unstructured":"Kim Y, Stolarska MA, Othmer HG. The role of the microenvironment in tumor growth and invasion. Prog Biophys Mol Biol. 2011;106(2):353\u201379.","journal-title":"Prog Biophys Mol Biol"},{"issue":"15","key":"2051_CR23","doi-asserted-by":"publisher","first-page":"158102","DOI":"10.1103\/PhysRevLett.110.158102","volume":"110","author":"P Ciarletta","year":"2013","unstructured":"Ciarletta P. Buckling instability in growing tumor spheroids. Phys Rev Lett. 2013;110(15):158102.","journal-title":"Phys Rev Lett"},{"key":"2051_CR24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s10237-008-0131-4","volume":"8","author":"G Xu","year":"2009","unstructured":"Xu G, Bayly PV, Taber LA. Residual stress in the adult mouse brain. Biomech Model Mechanobiol. 2009;8:253\u201362.","journal-title":"Biomech Model Mechanobiol"},{"key":"2051_CR25","doi-asserted-by":"crossref","unstructured":"Xu G, et al. Opening angles and material properties of the early embryonic chick brain. 2010 Jan;132(1):011005. doi: 10.1115\/1.4000169. PMID: 20524743; PMCID: PMC2882656.","DOI":"10.1115\/1.4000169"},{"key":"2051_CR26","doi-asserted-by":"crossref","unstructured":"Mow VC, et al. Biphasic creep and stress relaxation of articular cartilage in compression: theory and experiments. 1980 Feb;102(1):73-84. doi: 10.1115\/1.3138202. PMID: 7382457.","DOI":"10.1115\/1.3138202"},{"issue":"6","key":"2051_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s10237-007-0106-x","volume":"7","author":"LA Taber","year":"2008","unstructured":"Taber LA. Theoretical study of Beloussov\u2019s hyper-restoration hypothesis for mechanical regulation of morphogenesis. Biomech Model Mechanobiol. 2008;7(6):427\u201341.","journal-title":"Biomech Model Mechanobiol"},{"issue":"3","key":"2051_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0026-2862(03)00057-8","volume":"66","author":"T Roose","year":"2003","unstructured":"Roose T, et al. Solid stress generated by spheroid growth estimated using a linear poroelasticity model\u2606. Microvasc Res. 2003;66(3):204\u201312.","journal-title":"Microvasc Res"},{"issue":"2148","key":"2051_CR29","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1098\/rspa.2012.0418","volume":"468","author":"J MacLaurin","year":"2012","unstructured":"MacLaurin J, et al. The buckling of capillaries in solid tumours. Proceedings of the Royal Society A: Mathematical, Physical and Engineering Sciences. 2012;468(2148):4123\u201345.","journal-title":"Proc Royal Soc A: Math, Phys Eng Sci"},{"issue":"17","key":"2051_CR30","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1158\/0008-5472.CAN-05-0564","volume":"65","author":"LG de Pillis","year":"2005","unstructured":"de Pillis LG, Radunskaya AE, Wiseman CL. A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res. 2005;65(17):7950\u20138.","journal-title":"Cancer Res"},{"issue":"5","key":"2051_CR31","doi-asserted-by":"publisher","first-page":"e2306","DOI":"10.1371\/journal.pone.0002306","volume":"3","author":"D Fouchet","year":"2008","unstructured":"Fouchet D, Regoes R. A population dynamics analysis of the interaction between adaptive regulatory T cells and antigen presenting cells. PLoS ONE. 2008;3(5):e2306.","journal-title":"PLoS ONE"},{"issue":"7-8","key":"2051_CR32","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.mcm.2010.02.040","volume":"53","author":"NJ Burroughs","year":"2011","unstructured":"Burroughs NJ, et al. Immune response dynamics. Math Comput Model. 2011;53(7\u20138):1410\u20139.","journal-title":"Math Comput Model"},{"key":"2051_CR33","doi-asserted-by":"crossref","unstructured":"Abazari MA, Soltani M, Kashkooli FM. Targeted nano-sized drug delivery to heterogeneous solid tumor microvasculatures: implications for immunoliposomes exhibiting bystander killing effect. Phys Fluids. 2023;35(1): 011905. https:\/\/doi.org\/10.1063\/5.0130259","DOI":"10.1063\/5.0130259"},{"issue":"3","key":"2051_CR34","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","volume":"1","author":"PC Hermann","year":"2007","unstructured":"Hermann PC, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1(3):313\u201323.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"2051_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2184.1992.tb01433.x","volume":"25","author":"JJ Casciari","year":"1992","unstructured":"Casciari JJ, Sotirchos SV, Sutherland RM. Mathematical modelling of microenvironment and growth in EMT6\/Ro multicellular tumour spheroids. Cell Prolif. 1992;25(1):1\u201322.","journal-title":"Cell Prolif"},{"issue":"3","key":"2051_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.7150\/ntno.65544","volume":"6","author":"CK Lee","year":"2022","unstructured":"Lee CK, et al. Anti-PD-L1 f (ab) conjugated PEG-PLGA nanoparticle enhances immune checkpoint therapy. Nanotheranostics. 2022;6(3):243.","journal-title":"Nanotheranostics"},{"issue":"9","key":"2051_CR37","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1007\/s10439-015-1276-9","volume":"43","author":"T Stylianopoulos","year":"2015","unstructured":"Stylianopoulos T, et al. Towards optimal design of cancer nanomedicines: multi-stage nanoparticles for the treatment of solid tumors. Ann Biomed Eng. 2015;43(9):2291\u2013300.","journal-title":"Ann Biomed Eng"},{"issue":"17","key":"2051_CR38","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","volume":"31","author":"RK Jain","year":"2013","unstructured":"Jain RK. Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol. 2013;31(17):2205.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2051_CR39","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"6230","key":"2051_CR40","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/science.aaa8172","volume":"348","author":"P Sharma","year":"2015","unstructured":"Sharma P, Allison JP. The future of immune checkpoint therapy. Science. 2015;348(6230):56\u201361.","journal-title":"Science"},{"issue":"46","key":"2051_CR41","doi-asserted-by":"publisher","first-page":"18632","DOI":"10.1073\/pnas.1318415110","volume":"110","author":"T Stylianopoulos","year":"2013","unstructured":"Stylianopoulos T, Jain RK. Combining two strategies to improve perfusion and drug delivery in solid tumors. Proc Natl Acad Sci U S A. 2013;110(46):18632\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2051_CR42","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1172\/JCI96582","volume":"128","author":"X Zheng","year":"2018","unstructured":"Zheng X, et al. Increased vessel perfusion predicts the efficacy of immune checkpoint blockade. J Clin Invest. 2018;128(5):2104\u201315.","journal-title":"J Clin Invest"},{"issue":"22","key":"2051_CR43","doi-asserted-by":"publisher","first-page":"10674","DOI":"10.1073\/pnas.1819889116","volume":"116","author":"VP Chauhan","year":"2019","unstructured":"Chauhan VP, et al. Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy. Proc Natl Acad Sci U S A. 2019;116(22):10674\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2051_CR44","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s10237-015-0682-0","volume":"14","author":"F Mpekris","year":"2015","unstructured":"Mpekris F, et al. Stress-mediated progression of solid tumors: effect of mechanical stress on tissue oxygenation, cancer cell proliferation, and drug delivery. Biomech Model Mechanobiol. 2015;14:1391\u2013402.","journal-title":"Biomech Model Mechanobiol"},{"key":"2051_CR45","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12013-009-9047-6","volume":"53","author":"CT Mierke","year":"2009","unstructured":"Mierke CT. The role of vinculin in the regulation of the mechanical properties of cells. Cell Biochem Biophys. 2009;53:115\u201326.","journal-title":"Cell Biochem Biophys"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02051-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02051-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02051-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T12:57:28Z","timestamp":1788353848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02051-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,10]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2051"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02051-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,10]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This research is entirely computational and does not entail any physical experiment on live human or animal subjects or any live biological sample. The MRI images used to recreate the 3D structure of prostate cancer were sourced from TCIA, which is a publicly accessible repository of anonymized medical imagery. The TCIA database has received the appropriate permissions of the original data suppliers, and all details that identify patients have been eliminated. Hence, no extra ethics consent or participant permission is needed for the study.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. They have no financial or personal relationships with companies producing related devices, drugs, or software, and no intellectual property disputes are associated with this work.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}